Covered recipient · General Payments record
LISA ANN LINTZENICH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022
$152.73
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.73 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $36.35 | 2 |
| Novo Nordisk AS | $33.36 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.22 | 1 |
| Daiichi Sankyo Inc. | $17.45 | 1 |
| JAZZ PHARMACEUTICALS INC. | $17.29 | 1 |
| PFIZER INC. | $15.17 | 1 |
| Merck Sharp & Dohme Corporation | $11.89 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2022 | $152.73 | 9 |
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.22 | 07/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 887750135 | CMS |
| Daiichi Sankyo Inc. | $17.45 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 930842313 | CMS |
| JAZZ PHARMACEUTICALS INC. | $17.29 | 04/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951354701 | CMS |
| Lilly USA, LLC | $20.43 | 04/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918636097 | CMS |
| Lilly USA, LLC | $15.92 | 07/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918597339 | CMS |
| Merck Sharp & Dohme LLC | $11.89 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 944555463 | CMS |
| Novo Nordisk Inc | $20.27 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898582241 | CMS |
| Novo Nordisk Inc | $13.09 | 08/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899193083 | CMS |
| PFIZER INC. | $15.17 | 04/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 949380907 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022
- Source files
- Dataset page · Bulk file · PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.